These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22928242)

  • 1. Should we limit participation in the ESRD Program?
    Sullivan JD; McGue WF
    Nephrol News Issues; 2012 Jun; 26(7):28, 30-2. PubMed ID: 22928242
    [No Abstract]   [Full Text] [Related]  

  • 2. The 2011 ESRD prospective payment system: an uncontrolled experiment.
    Winkelmayer WC; Chertow GM
    Am J Kidney Dis; 2011 Apr; 57(4):542-6. PubMed ID: 21333428
    [No Abstract]   [Full Text] [Related]  

  • 3. The 2011 ESRD prospective payment system: welcome to the bundle.
    Weiner DE
    Am J Kidney Dis; 2011 Apr; 57(4):539-41. PubMed ID: 21333431
    [No Abstract]   [Full Text] [Related]  

  • 4. The 2011 ESRD prospective payment system: perspectives from Fresenius Medical Care, a large dialysis organization.
    Lacson E; Hakim RM
    Am J Kidney Dis; 2011 Apr; 57(4):547-9. PubMed ID: 21333423
    [No Abstract]   [Full Text] [Related]  

  • 5. Can we revitalize the ESRD program?
    McFeeley T
    Nephrol News Issues; 2004 Apr; 18(5):42-3, 47, 87. PubMed ID: 15125164
    [No Abstract]   [Full Text] [Related]  

  • 6. The 2011 ESRD prospective payment system: perspectives from a for-profit small- to medium-sized dialysis organization.
    Bhat P; Bhat JG
    Am J Kidney Dis; 2011 Apr; 57(4):556-8. PubMed ID: 21316132
    [No Abstract]   [Full Text] [Related]  

  • 7. The 2011 ESRD prospective payment system: perspectives from DaVita, a for-profit large dialysis organization.
    Nissenson AR; Mayne TJ; Krishnan M
    Am J Kidney Dis; 2011 Apr; 57(4):550-2. PubMed ID: 21333425
    [No Abstract]   [Full Text] [Related]  

  • 8. The 2011 ESRD prospective payment system and the survival of an endangered species: the perspective of a not-for-profit medium-sized dialysis organization.
    Johnson DS; Meyer KB; Johnson HK
    Am J Kidney Dis; 2011 Apr; 57(4):553-5. PubMed ID: 21333427
    [No Abstract]   [Full Text] [Related]  

  • 9. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia.
    Prodjosudjadi W
    Ethn Dis; 2006; 16(2 Suppl 2):S2-14-6. PubMed ID: 16774003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The organization of medical care. Lessons from the Medicare end stage renal disease program.
    Levinsky NG
    N Engl J Med; 1993 Nov; 329(19):1395-9. PubMed ID: 8413437
    [No Abstract]   [Full Text] [Related]  

  • 11. Dialysis rationing in South Africa: a global message.
    Dirks JH; Levin NW
    Kidney Int; 2006 Sep; 70(6):982-4. PubMed ID: 16957745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESRD modality selection into the 21st century: the importance of non medical factors.
    Nissenson AR; Prichard SS; Cheng IK; Gokal R; Kubota M; Maiorca R; Riella MC; Rottembourg J; Stewart JH
    ASAIO J; 1997; 43(3):143-50. PubMed ID: 9152482
    [No Abstract]   [Full Text] [Related]  

  • 13. Technical and economic strategies of maintenance dialysis in the UK and Nordic Countries.
    Cantaluppi A; East P
    J Nephrol; 2000; 13 Suppl 3():S10-5. PubMed ID: 11132025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What price success?
    Tecnologica; 1996 Nov; ():1-6. PubMed ID: 10179816
    [No Abstract]   [Full Text] [Related]  

  • 15. The American health care system. The End Stage Renal Disease Program.
    Iglehart JK
    N Engl J Med; 1993 Feb; 328(5):366-71. PubMed ID: 8419833
    [No Abstract]   [Full Text] [Related]  

  • 16. Rationing of health care and the end-stage renal disease program.
    Klahr S
    Am J Kidney Dis; 1990 Oct; 16(4):392-5. PubMed ID: 2220792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. God panels and the history of hemodialysis in America: a cautionary tale.
    Ross W
    Virtual Mentor; 2012 Nov; 14(11):890-6. PubMed ID: 23351904
    [No Abstract]   [Full Text] [Related]  

  • 18. ESRD program at the crossroads of health care reform.
    Neumann ME
    Nephrol News Issues; 1993 Oct; 7(10):5, 40. PubMed ID: 8232632
    [No Abstract]   [Full Text] [Related]  

  • 19. HMOs and ESRD: a gloomy scenario.
    Steinman TI
    Nephrol News Issues; 1998 May; 12(5 Suppl):30, 33. PubMed ID: 9652298
    [No Abstract]   [Full Text] [Related]  

  • 20. The end stage renal disease program.
    Robertson JS; Graves J
    N Engl J Med; 1993 Jul; 329(2):139; author reply 140-1. PubMed ID: 8510700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.